Because previous studies coupled ITGB3 to EMT and metastasis, and silencing of ITGB3 by a variety of approach has been demonstrated to rescue from metastasis formation in several cancer models, our study suggest that targeting this integrin could be useful in the treatment of gastric cancer. Here, ITGB3 is linked to gastric cancer.